Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer. [electronic resource]
Producer: 20160113Description: 22-7 p. digitalISSN:- 2589-0646
- Administration, Metronomic
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Capecitabine -- administration & dosage
- Chemotherapy, Adjuvant
- Disease-Free Survival
- Drug Chronotherapy
- Female
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.